Korea Investment CORP Sells 56,956 Shares of Cencora, Inc. $COR

Korea Investment CORP lowered its position in Cencora, Inc. (NYSE:COR) by 32.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 116,478 shares of the company’s stock after selling 56,956 shares during the period. Korea Investment CORP’s holdings in Cencora were worth $36,403,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the company. IAG Wealth Partners LLC acquired a new stake in Cencora in the third quarter valued at approximately $30,000. Cloud Capital Management LLC acquired a new position in shares of Cencora during the third quarter worth $31,000. Caitlin John LLC acquired a new position in shares of Cencora during the third quarter worth $31,000. Vermillion & White Wealth Management Group LLC lifted its holdings in shares of Cencora by 69.4% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock valued at $31,000 after purchasing an additional 43 shares during the last quarter. Finally, Westside Investment Management Inc. lifted its holdings in shares of Cencora by 200.0% during the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock valued at $33,000 after purchasing an additional 70 shares during the last quarter. Institutional investors own 97.52% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. TD Cowen boosted their target price on Cencora from $350.00 to $400.00 and gave the stock a “buy” rating in a research note on Monday, November 10th. JPMorgan Chase & Co. increased their price target on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Bank of America lowered their price target on Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a report on Monday, January 5th. Weiss Ratings upgraded shares of Cencora from a “hold (c+)” rating to a “buy (b)” rating in a report on Thursday, February 5th. Finally, Wells Fargo & Company increased their price objective on shares of Cencora from $405.00 to $429.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Eleven investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, Cencora presently has a consensus rating of “Moderate Buy” and an average target price of $399.00.

Insider Buying and Selling

In related news, EVP Elizabeth S. Campbell sold 3,351 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $342.10, for a total value of $1,146,377.10. Following the sale, the executive vice president owned 23,891 shares in the company, valued at $8,173,111.10. This represents a 12.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Robert P. Mauch sold 5,096 shares of the stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the transaction, the chief executive officer owned 66,726 shares in the company, valued at approximately $23,669,713.98. This trade represents a 7.10% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 15,220 shares of company stock valued at $5,282,867 over the last quarter. 0.38% of the stock is currently owned by company insiders.

Cencora Price Performance

NYSE COR opened at $361.80 on Tuesday. The company has a market cap of $70.38 billion, a price-to-earnings ratio of 43.49, a PEG ratio of 1.67 and a beta of 0.68. The company has a debt-to-equity ratio of 3.62, a current ratio of 0.92 and a quick ratio of 0.51. The stock’s fifty day moving average price is $354.60 and its 200 day moving average price is $337.09. Cencora, Inc. has a 1 year low of $251.94 and a 1 year high of $377.54.

Cencora (NYSE:COR) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, topping analysts’ consensus estimates of $4.04 by $0.04. The company had revenue of $85.93 billion during the quarter, compared to analysts’ expectations of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The firm’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.73 EPS. As a group, equities research analysts forecast that Cencora, Inc. will post 15.37 earnings per share for the current year.

Cencora Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. Cencora’s payout ratio is 28.85%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.